menu

Pathways to Precision Medicine: An Overview of NSCLC & Multi-Biomarker Testing

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Pathways to Precision Medicine: An Overview of NSCLC & Multi-Biomarker Testing

close
Pathways to Precision Medicine: An Overview of NSCLC & Multi-Biomarker Testing
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    What are some of the clinical considerations for RET-rearranged non-small cell lung cancer? Dr. Ross Camidge, Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, briefly discusses the guidelines and benefits of therapy recommended for non-small cell lung cancer by the National Comprehensive Cancer Network.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    What are some of the clinical considerations for RET-rearranged non-small cell lung cancer? Dr. Ross Camidge, Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, briefly discusses the guidelines and benefits of therapy recommended for non-small cell lung cancer by the National Comprehensive Cancer Network.

Facebook Comments

Programs 8/1/21